Literature DB >> 16187869

Negative cognitive styles, dysfunctional attitudes, and the remitted depression paradigm: a search for the elusive cognitive vulnerability to depression factor among remitted depressives.

Gerald J Haffel1, Lyn Y Abramson, Zachary R Voelz, Gerald I Metalsky, Lisa Halberstadt, Benjamin M Dykman, Patricia Donovan, Michael E Hogan, Benjamin L Hankin, Lauren B Alloy.   

Abstract

Results from studies using a behavioral high-risk design and approximations to it generally have corroborated the cognitive vulnerability hypothesis of depression, whereas results from remitted depression studies typically have not. Suspecting that design features of previously conducted remitted designs likely precluded them from detecting maladaptive cognitive patterns, the authors conducted a study featuring the remitted design that has been successful in studies of a biological vulnerability for depression. Participants' current depressive symptoms, negative cognitive styles (hopelessness theory), dysfunctional attitudes (Beck's theory), and lifetime prevalence of clinically significant depression were assessed. Participants who had remitted from an episode of clinically significant depression had more negative cognitive styles, but not greater levels of dysfunctional attitudes, than did never depressed individuals. ((c) 2005 APA, all rights reserved).

Entities:  

Mesh:

Year:  2005        PMID: 16187869     DOI: 10.1037/1528-3542.5.3.343

Source DB:  PubMed          Journal:  Emotion        ISSN: 1528-3542


  24 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Measurement of negativity bias in personal narratives using corpus-based emotion dictionaries.

Authors:  Shuki J Cohen
Journal:  J Psycholinguist Res       Date:  2011-04

3.  Measuring cognitive vulnerability to depression: development and validation of the cognitive style questionnaire.

Authors:  Gerald J Haeffel; Brandon E Gibb; Gerald I Metalsky; Lauren B Alloy; Lyn Y Abramson; Benjamin L Hankin; Thomas E Joiner; Joel D Swendsen
Journal:  Clin Psychol Rev       Date:  2007-12-23

4.  Enhanced negative feedback responses in remitted depression.

Authors:  Diane L Santesso; Katherine T Steele; Ryan Bogdan; Avram J Holmes; Christen M Deveney; Tiffany M Meites; Diego A Pizzagalli
Journal:  Neuroreport       Date:  2008-07-02       Impact factor: 1.837

5.  High and Low Cognitive Risk For Depression: Stability From Late Adolescence to Early Adulthood.

Authors:  Sara E Romens; Lyn Y Abramson; Lauren B Alloy
Journal:  Cognit Ther Res       Date:  2009

6.  Depression history, depression vulnerability and the experience of everyday negative events.

Authors:  Megan A O'Grady; Howard Tennen; Stephen Armeli
Journal:  J Soc Clin Psychol       Date:  2010-11

7.  Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care.

Authors:  Robin B Jarrett; Abu Minhajuddin; Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase
Journal:  J Consult Clin Psychol       Date:  2015-12-14

8.  Cognitive Attributions in Depression: Bridging the Gap between Research and Clinical Practice.

Authors:  Liza M Rubenstein; Rachel D Freed; Benjamin G Shapero; Robert L Fauber; Lauren B Alloy
Journal:  J Psychother Integr       Date:  2016-06

9.  Implicit depression and hopelessness in remitted depressed individuals.

Authors:  Tiffany M Meites; Christen M Deveney; Katherine T Steele; Avram J Holmes; Diego A Pizzagalli
Journal:  Behav Res Ther       Date:  2008-06-27

10.  Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Robin B Jarrett
Journal:  J Affect Disord       Date:  2008-06-09       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.